AGM/EGMApr 28, 2026, 05:07 PM
IOVA Proposes 1M ESPP Shares, 150M Authorized Common Shares
AI Summary
Iovance Biotherapeutics, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on Wednesday, June 10, 2026. Key proposals include the election of six directors, advisory votes on executive compensation and its frequency, and the ratification of Ernst & Young LLP as the independent auditor. The company also seeks approval to amend its 2020 Employee Stock Purchase Plan to increase authorized shares by 1,000,000 and to increase the total authorized common stock from 500,000,000 to 650,000,000 shares. Additionally, director Wendy Yarno will retire from the Board and will not stand for re-election.
Key Highlights
- Proposes to increase 2020 ESPP authorized shares by 1,000,000.
- Proposes to increase authorized common stock from 500,000,000 to 650,000,000 shares.
- Annual Meeting of Stockholders scheduled for June 10, 2026, virtually.
- Six directors nominated for election to serve until the 2027 Annual Meeting.
- Non-binding advisory vote on named executive officer compensation.
- Non-binding advisory vote on frequency of future 'say on pay' votes.
- Ratification of Ernst & Young LLP as independent auditor for fiscal year 2026.
- Director Wendy Yarno to retire and not stand for re-election.
Price Impact
More from IOVA